✦ LIBER ✦

Recommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders

✍ Scribed by R. Lassila; C. Rothschild; P. de Moerloose; M. Richards; R. Perez; H. Gajek; on behalf of the European Haemophilia Therapy Standardisation Board (EHTSB)

Book ID: 108772466
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 69 KB
Volume: 11
Category: Article
ISSN: 1351-8216
DOI: 10.1111/j.1365-2516.2005.01114.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A framework for genetic service provisio

A framework for genetic service provision for haemophilia and other inherited bleeding disorders

✍ C. A. Ludlam; K. J. Pasi; P. Bolton-Maggs; P. W. Collins; A. M. Cumming; G. Dola 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Surveillance of female patients with inh

Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres

✍ V. R. BYAMS; P. A. KOUIDES; R. KULKARNI; J. R. BAKER; D. L. BROWN; J. C. GILL; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Robustness of factor assays following co

Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders

✍ S. SHETTY; K. GHOSH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

A postmarketing surveillance study of th

A postmarketing surveillance study of the safety and efficacy of ReFacto® (St Louis-derived active substance) in patients with haemophilia A

✍ M. P. Smith; P. Giangrande; H. Pollman; R. Littlewood; C. Kollmer; J. Feingold; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Efficacy, safety and tolerability of rec

Efficacy, safety and tolerability of recombinant factor VIII (REFACTO®) in patients with haemophilia A: interim data from a postmarketing surveillance study in Germany and Austria

✍ H. POLLMANN; D. EXTERNEST; A. GANSER; B. EIFRIG; W. KREUZ; H. LENK; I. PABINGER; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Beta interferon therapy for chronic hepa

Beta interferon therapy for chronic hepatitis C in patients with haemophilia and other haemorrhagic disorders

✍ T. HAGIWARA; H. FUKUE; K. KAWATA; T. YAMAGISHI; Y. YAMAMOTO; M. ARAI; K. FUKUTAK 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB